Mentalizing Imagery Therapy for Caregivers to Address Risk of Elder Mistreatment ((MIT-CARE))
2026年6月9日 更新者:Wesley Browning、The University of Texas Health Science Center, Houston
Mentalizing Imagery Therapy for Caregivers to Address Risk of Elder Mistreatment (MIT-CARE)
The purpose of this study is to establish the clinical efficacy of Mentalizing Imagery Therapy (MIT) for Alzheimer's Disease and Related Disorders (ADRD) family caregivers in terms of mentalizing and elder mistreatment (EM) risk factors of stress, depression, and suicidality and to identify the mechanistic impacts of MIT on ADRD family caregivers' mental health,including stress, depression, and suicidality.
研究概览
研究类型
介入性
注册 (估计的)
50
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习联系方式
- 姓名:Wesley Browning, PhD
- 电话号码:256.270.5286
- 邮箱:wesley.r.browning@uth.tmc.edu
研究联系人备份
- 姓名:Asha Jacob
- 电话号码:(713) 500-2187
- 邮箱:Asha.P.Jacob@uth.tmc.edu
学习地点
-
-
Texas
-
Houston、Texas、美国、77030
- The University of Texas Health Science Center at Houston
-
接触:
- Wesley Browning, PhD
- 电话号码:256.270.5286
- 邮箱:wesley.r.browning@uth.tmc.edu
-
接触:
- Asha Jacob
- 电话号码:(713) 500-2187
- 邮箱:Asha.P.Jacob@uth.tmc.edu
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 孩子
- 成人
- 年长者
接受健康志愿者
不
描述
Inclusion Criteria:
- Primary family ADRD caregivers
- Recruited nationally.
- Caring for someone aged 60 or older
- Provide at least 8 hours of care weekly
- Report at least mild depressive symptoms (PHQ-9 ≥5)
- Use a smartphone at least five days per week.
Exclusion Criteria:
- Active psychosis or mania
- A suicide attempt in the last 6 months or current suicidal intent
- Self-reported memory or cognitive complaints
- Unstable medical conditions or planned major surgery
- Moderate to severe substance use disorders.
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:交叉作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:4 weeks of MIT followed by 4 weeks of ME with 2 weeks of washout period in between
|
MIT is a 4-week, app-delivered behavioral program integrating guided imagery, mindfulness, and perspective-taking practices designed to enhance mentalizing, emotion regulation, and self compassion.
MIT is reinforced by weekly 90-minute virtual group sessions
Mindfulness exercises (ME) is a 4-week, app-delivered program featuring daily self-guided mindfulness practices and reflective exercises aimed at reducing depression and stress.ME is self-guided and does not include group sessions.
|
|
实验性的:4 weeks of ME, followed by 4 weeks of MIT with 2 weeks of washout period in between
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in perceived stress as measured by self-reported daily stress
大体时间:From Baseline through Week 10
|
This is scored on a scale from 0-10, with 0 indicating no stress, and 10 indicating the day was extremely stressful
|
From Baseline through Week 10
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in perceived stress as measured by Perceived Stress Scale (PSS)
大体时间:Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10
|
The PSS is a 10-item psychological instrument measuring the degree to which situations in one's life are appraised as stressful.
Items are scored from 0-4, with total scores ranging from 0-40.
Higher scores indicate greater perceived stress.
|
Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10
|
|
Change in depression as measured by Patient Health Questionnaire-9 (PHQ-9)
大体时间:Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10
|
PHQ-9 is a 9-item self-report measure used to assess the severity of depressive symptoms .
Each item is scored from 0 ("Not at all") to 3 ("Nearly every day"), resulting in a total score ranging from 0 to 27.
Higher scores indicate greater depressive symptom severity.
|
Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10
|
|
Depression as measured by self-rated daily depression severity
大体时间:From baseline through Week 10
|
this will be reported as the number of times participant felt feel depressed, sad, or hopeless each day
|
From baseline through Week 10
|
|
Suicidality as measured by self-reported daily suicidality
大体时间:From baseline through Week 10
|
this will be reported as the number of times participant felt they would be better off dead or thinking about hurting themselves each day
|
From baseline through Week 10
|
|
Change in Mentalization as Measured by the Mentalization Questionnaire (MZQ)
大体时间:Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10
|
This is a 15 item questionnaire and each is scored on a 5-point Likert scale for a score range from 15-75.
Higher scores often indicate greater mentalizing deficits
|
Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10
|
|
Change in Mindfulness as Measured by the Mindfulness Subscale of the Self-Compassion Scale (SCS)
大体时间:Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10
|
The subscale consists of 4 items rated on a 5-point Likert scale ranging from 1 ("Almost Never") to 5 ("Almost Always").
Scores are calculated as the mean of the item responses, with higher scores indicating greater mindfulness.
|
Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10
|
|
Change in Self-compassion as measured by the Self-Compassion Scale
大体时间:Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10
|
This has 26 items rated on a 5-point Likert scale ranging from 1 ("Almost Never") to 5 ("Almost Always").
Scores are calculated by averaging item responses after reverse-scoring negatively worded items.
Total scores range from 1 to 5, with higher scores indicating greater self-compassion
|
Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10
|
|
Emotion Regulation as measured by self-reported daily emotion regulation
大体时间:From baseline through Week 10
|
This will be reported as number of times participant felt angry or anxious and how often they lost control over their behaviors each day
|
From baseline through Week 10
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Wesley Browning, PhD、The University of Texas Health Science Center, Houston
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (估计的)
2026年8月1日
初级完成 (估计的)
2027年9月1日
研究完成 (估计的)
2028年6月30日
研究注册日期
首次提交
2026年6月9日
首先提交符合 QC 标准的
2026年6月9日
首次发布 (实际的)
2026年6月15日
研究记录更新
最后更新发布 (实际的)
2026年6月15日
上次提交的符合 QC 标准的更新
2026年6月9日
最后验证
2026年6月1日
更多信息
与本研究相关的术语
其他研究编号
- HSC-SN-25-0900
- 5P30AG086563-02 (美国 NIH 拨款/合同)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
不
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.